Levels of non-high-density-lipoprotein cholesterol are positively correlated with the risk of cognitive impairment in patients with intracerebral hemorrhage stroke

References

• Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–369.
   PubMed Web of Science ®Google Scholar
• Sacco S, Marini C, Toni D, et al. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009;40(2):394–399.
   PubMed Web of Science ®Google Scholar
• Hong KS, Bang OY, Kang DW, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke. 2013;15(1):2–20.
   PubMed Web of Science ®Google Scholar
• Toyoda K. Epidemiology and registry studies of stroke in Japan. J Stroke. 2013;15(1):21–26.
   PubMed Web of Science ®Google Scholar
• Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–731.
   PubMed Web of Science ®Google Scholar
• Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987;18(2):311–324.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Yamanouchi H, Kuzuhara S, et al. Dementia in cerebral amyloid angiopathy: a clinicopathological study. J Neurol. 1992;239(8):441–450.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III.). JAMA. 2001;285(19):2486–2497.
   PubMed Web of Science ®Google Scholar
• Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke. 2013;44(8):2330–2332.
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Maki KC, Orringer CE, NLA Expert Panel, et al. National Lipid Association Recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol. 2015;9(6 Suppl):S1–122 e1.
   PubMed Web of Science ®Google Scholar
• Molloy DW, Standish TI. A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr. 1997;9 Suppl 1 (Suppl 1):87–94.
   PubMedGoogle Scholar
• Hu JB, Zhou WH, Hu SH, et al. Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings. Arch Gerontol Geriatr. 2013;56(1):38–43.
   PubMed Web of Science ®Google Scholar
• Wang T, Xiao S, Li X, et al. Reliability and validity of the Chinese version of the neuropsychiatric inventory in mainland China. Int J Geriatr Psychiatry. 2012;27(5):539–544.
   PubMed Web of Science ®Google Scholar
• Eto FT, Chishima M, Igarashi M, et al. [Comprehensive activities of daily living (ADL) index for the elderly]. Nihon Ronen Igakkai Zasshi. 1992;29(11):841–848.
   PubMedGoogle Scholar
• Faries D, Herrera J, Rayamajhi J, et al. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res. 2000;34(1):3–10.
   PubMed Web of Science ®Google Scholar
• Bittner V, Hardison R, Kelsey SF, Bypass Angioplasty Revascularization Investigation, et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 2002;106(20):2537–2542.
   PubMed Web of Science ®Google Scholar
• Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161(11):1413–1419.
   PubMedGoogle Scholar
• Wu J, Chen S, Liu L, et al. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study. Neurol Res. 2013;35(5):505–511.
   PubMed Web of Science ®Google Scholar
• Wu J, Chen S, Zhou Y, et al. Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study. PLoS One. 2013;8(9):e74634.
   PubMed Web of Science ®Google Scholar
• Niu MJ, Yin FZ, Liu LX, et al. Non-high-density lipoprotein cholesterol and other risk factors of mild cognitive impairment among Chinese type 2 diabetic patients. J Diabetes Complications. 2013;27(5):443–446.
   PubMed Web of Science ®Google Scholar
• Reed B, Villeneuve S, Mack W, et al. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014;71(2):195–200.
   PubMed Web of Science ®Google Scholar
• Canoui-Poitrine F, Luc G, Bard JM, PRIME Study Group, et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis. 2010;30(3):252–259.
   PubMed Web of Science ®Google Scholar
• Erqou S, Kaptoge S, Perry PL, Emerging Risk Factors Collaboration, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–423.
   PubMed Web of Science ®Google Scholar
• Lu D, Li P, Zhou Y, et al. Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke. BMC Neurol. 2016;16(1):154.
   PubMedGoogle Scholar
• Wang YL, Zhang M, Zhang H-h, et al. Cross-sectional analysis of cognitive impairment and relative factors after acute ischemic stroke. Chi J Contemp Neurol Neurosurg. 2013;13:279–285.
   Google Scholar
• Zhou F, Deng W, Ding D, et al. High low-density lipoprotein cholesterol inversely relates to dementia in community-dwelling older adults: the Shanghai aging study. Front Neurol. 2018;12;9.
   Google Scholar
• Grasset L, Smit RAJ, Caunca MR, et al. Association of high-density lipoprotein cholesterol with cognitive function: findings from the PROspective Study of Pravastatin in the elderly at risk. J Aging Health. 2020. DOI:10.1177/0898264320916959
   PubMed Web of Science ®Google Scholar
• Gencer B, Mach F, Guo JP, et al. Cognition after lowering LDL-cholesterol with evolocumab. J Am Coll Cardiol. 2020;75(18):2283–2293.
   PubMed Web of Science ®Google Scholar
• Yang FN, Stanford M, Jiang X. Low cholesterol level linked to reduced semantic fluency performance and reduced gray matter volume in the medial temporal lobe. Front Aging Neurosci. 2020;12:57.
   PubMed Web of Science ®Google Scholar
• Rohr F, Bucholtz N, Toepfer S, et al. Relationship between lipoprotein (a) and cognitive function - results from the Berlin Aging Study II. Sci Rep. 2020;10(1):1–10.
   PubMed Web of Science ®Google Scholar
• Svensson T, Sawada N, Mimura M, et al. The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up. Transl Psychiat. 2019;9:1–9.
   PubMed Web of Science ®Google Scholar